188 related articles for article (PubMed ID: 22999240)
1. Postprandial dysmetabolism and the heart.
Garber AJ
Heart Fail Clin; 2012 Oct; 8(4):563-73. PubMed ID: 22999240
[TBL] [Abstract][Full Text] [Related]
2. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor.
O'Keefe JH; Bell DS
Am J Cardiol; 2007 Sep; 100(5):899-904. PubMed ID: 17719342
[TBL] [Abstract][Full Text] [Related]
3. Natural antioxidant compounds in risk factors for CVD.
Kaliora AC; Dedoussis GV
Pharmacol Res; 2007 Aug; 56(2):99-109. PubMed ID: 17572098
[TBL] [Abstract][Full Text] [Related]
4. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.
Tushuizen ME; Diamant M; Heine RJ
Postgrad Med J; 2005 Jan; 81(951):1-6. PubMed ID: 15640422
[TBL] [Abstract][Full Text] [Related]
5. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
Sjöholm A
Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
[TBL] [Abstract][Full Text] [Related]
6. Role of postprandial hyperglycemia in cardiovascular disease.
Fava S
Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):859-72. PubMed ID: 18570623
[TBL] [Abstract][Full Text] [Related]
7. [Thiazolidinediones: effect of the pioglitazone on hyperglycemia, dyslipidemia and cardiovascular risk].
Tan MH
Rev Clin Esp; 2003 Jan; 203(1):33-40. PubMed ID: 12605799
[No Abstract] [Full Text] [Related]
8. Postprandial hyperglycemia on vascular endothelial function: mechanisms and consequences.
Mah E; Bruno RS
Nutr Res; 2012 Oct; 32(10):727-40. PubMed ID: 23146769
[TBL] [Abstract][Full Text] [Related]
9. Postprandial hyperglycemia and hyperlipidemia-generated glycoxidative stress: its contribution to the pathogenesis of diabetes complications.
Rebolledo OR; Actis Dato SM
Eur Rev Med Pharmacol Sci; 2005; 9(4):191-208. PubMed ID: 16128039
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
[TBL] [Abstract][Full Text] [Related]
11. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
Paraskevas KI
J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
[No Abstract] [Full Text] [Related]
12. Postprandial hyperglycemia as an etiological factor in vascular failure.
Node K; Inoue T
Cardiovasc Diabetol; 2009 Apr; 8():23. PubMed ID: 19402896
[TBL] [Abstract][Full Text] [Related]
13. Postprandial glucose regulation and diabetic complications.
Ceriello A; Hanefeld M; Leiter L; Monnier L; Moses A; Owens D; Tajima N; Tuomilehto J
Arch Intern Med; 2004 Oct; 164(19):2090-5. PubMed ID: 15505121
[TBL] [Abstract][Full Text] [Related]
14. [Postprandial hyperglycemia and diabetic complications].
Da Ros R; Assaloni R; Ceriello A
Recenti Prog Med; 2005 Sep; 96(9):436-44. PubMed ID: 16229326
[TBL] [Abstract][Full Text] [Related]
15. Myocardial fatty acid metabolism and lipotoxicity in the setting of insulin resistance.
Kok BP; Brindley DN
Heart Fail Clin; 2012 Oct; 8(4):643-61. PubMed ID: 22999246
[TBL] [Abstract][Full Text] [Related]
16. [The role of postprandial hyperglycemia in the development of cardiovascular diseases in type 2 diabetes mellitus].
Shvarts V
Klin Med (Mosk); 2009; 87(11):17-24. PubMed ID: 20143560
[TBL] [Abstract][Full Text] [Related]
17. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
Duntas L; Kolovou G
Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
[No Abstract] [Full Text] [Related]
18. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation.
Azuma K; Toyofuku Y; Iesaki T; Otsuka A; Tanaka A; Mita T; Hirose T; Tanaka Y; Daida H; Kawamori R; Watada H
Biochem Biophys Res Commun; 2006 Jun; 345(2):688-93. PubMed ID: 16696939
[TBL] [Abstract][Full Text] [Related]
19. Potential cardiovascular benefits of insulin sensitizers.
Kunhiraman BP; Jawa A; Fonseca VA
Endocrinol Metab Clin North Am; 2005 Mar; 34(1):117-35. PubMed ID: 15752925
[TBL] [Abstract][Full Text] [Related]
20. Lipid lowering with dietary supplements: focus on diabetes.
Rudkowska I
Maturitas; 2012 Jun; 72(2):113-6. PubMed ID: 22459005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
